Metformin, an inexpensive drug that has been prescribed for diabetes for decades, may lower breast cancer risk in patients with type 2 diabetes. For diabetic patients, metformin provides about a 30% reduction in the lifetime risk of all cancers.
Breast cancer and glucose: metformin
